Abstract |
In this article, the in vitro effects of seleno-short-chain chitosan (SSCC, molecular weight between 5,000 and 10,000 Da) on the proliferation of human leukemia K562 cells were investigated to illustrate the possible mechanisms involved. 3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) assays showed that short-chain chitosan significantly suppressed the growth of K562 cells in a dose-dependent and time-dependent manner, although normal mouse embryonic fibroblasts NIH3T3 were viable after the same treatment. Cell growth inhibitory rate could reach 95% after exposure with more than 100 microg/ml SSCC for 72 h. Flow cytometry analysis revealed that treatment of K562 cells with SSCC resulted in the accumulation of cells in the G(2)/M phase. The growth inhibition of K562 cells after treatment with SSCC was subsequently associated with the induction of apoptosis, as evidenced by (1) the typical apoptotic morphologic changes measured by a fluorescence microscope, (2) the internucleosomal DNA fragmentation into a ladder determined by agarose gel electrophoresis and (3) the occurrence of sub-G(0)/G(1) phase cells analyzed by flow cytometry. All these results indicated that SSCC may have therapeutic potential in human leukemia treatment.
|
Authors | A Liu, W Song, D Cao, X Liu, Y Jia |
Journal | Methods and findings in experimental and clinical pharmacology
(Methods Find Exp Clin Pharmacol)
Vol. 30
Issue 3
Pg. 181-6
(Apr 2008)
ISSN: 0379-0355 [Print] Spain |
PMID | 18597001
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright 2008 Prous Science, S.A.U. or its licensors. All rights reserved. |
Chemical References |
- Antineoplastic Agents
- Organoselenium Compounds
- Selenium Compounds
- seleno-short-chain chitosan
- Chitosan
- Selenic Acid
|
Topics |
- Antineoplastic Agents
(pharmacology)
- Apoptosis
(drug effects)
- Cell Division
(drug effects)
- Cell Proliferation
(drug effects)
- Cell Survival
(drug effects)
- Chitosan
(pharmacology)
- Flow Cytometry
- Humans
- K562 Cells
- Leukemia
(pathology)
- Organoselenium Compounds
(pharmacology)
- Selenic Acid
- Selenium Compounds
(chemistry)
|